Paradoxical Stimulation of Hepatic Glucose Production With Dapagliflozin

NCT02984644 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Type II; Diabetes

Interventions

DRUG: Dapagliflozin
DRUG: Placebo

Sponsor

The University of Texas Health Science Center at San Antonio